Literature DB >> 19559837

Management of transmesenteric tunnel jejunal strictures with endoscopic dilation by using achalasia balloons (with videos).

Shou-jiang Tang1, David A Provost, Edward Livingston, Daniel J Scott.   

Abstract

BACKGROUND: Roux-en-Y gastric bypass is the most commonly performed bariatric operation in the United States. Transmesenteric tunnel (TMT) or mesocolic jejunal stricture is an unusual postoperative complication that requires another operation. We hypothesize that endoscopic dilation by using achalasia dilatation balloons can be used to treat some TMT jejunal strictures. PATIENTS: This study involved 6 consecutive cases of TMT stricture. INTERVENTION: The TMT strictures were dilated by using achalasia balloons (30-40 mm) under fluoroscopic and endoscopic guidance.
RESULTS: With endotherapy, 4 patients with late onset of symptoms (>3 weeks after Roux-en-Y gastric bypass) have not required another operation to date, with a follow-up of at least 5 to 12 months. Two patients with early onset of symptoms (<3 weeks after surgery) required operations, and 1 of these patients (symptoms onset <7 days after surgery) developed jejunal perforation within the stricture during dilation due to underlying jejunal ischemia within the stricture. LIMITATIONS: Small case number and limited follow-up period.
CONCLUSION: Endoscopic dilation by using achalasia balloons can be used to treat some TMT jejunal strictures without another operation. Surgery should be considered in patients with early onset of obstructive symptoms and/or with jejunal ischemia within the stricture.

Entities:  

Mesh:

Year:  2009        PMID: 19559837     DOI: 10.1016/j.gie.2009.02.011

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  1 in total

1.  Food intolerance after banded gastric bypass without stenosis: aggressive endoscopic dilation avoids reoperation.

Authors:  Alvaro Ferraz; Josemberg Campos; Victor Dib; Lyz B Silva; Patrícia S de Paula; Amador Gordejuela; Felippe Rolim; Luciana Siqueira; Manoel Galvão Neto
Journal:  Obes Surg       Date:  2013-07       Impact factor: 4.129

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.